RU2002108566A - New Chalcones - Google Patents
New ChalconesInfo
- Publication number
- RU2002108566A RU2002108566A RU2002108566/04A RU2002108566A RU2002108566A RU 2002108566 A RU2002108566 A RU 2002108566A RU 2002108566/04 A RU2002108566/04 A RU 2002108566/04A RU 2002108566 A RU2002108566 A RU 2002108566A RU 2002108566 A RU2002108566 A RU 2002108566A
- Authority
- RU
- Russia
- Prior art keywords
- atoms
- group
- substituents
- unsubstituted
- substituted
- Prior art date
Links
- 150000001789 chalcones Chemical class 0.000 title 1
- 229930016212 chalcones Natural products 0.000 title 1
- 235000005513 chalcones Nutrition 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 claims 28
- 125000004429 atoms Chemical group 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 19
- 125000002837 carbocyclic group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 125000004122 cyclic group Chemical group 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 14
- 125000000623 heterocyclic group Chemical group 0.000 claims 14
- 229940079593 drugs Drugs 0.000 claims 11
- 239000004215 Carbon black (E152) Substances 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 125000005842 heteroatoms Chemical group 0.000 claims 9
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 230000002265 prevention Effects 0.000 claims 8
- -1 N, N-dimethylaminophenyl Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 239000002246 antineoplastic agent Substances 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N Docetaxel Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 3
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 3
- 229960001592 Paclitaxel Drugs 0.000 claims 3
- 229960003668 docetaxel Drugs 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229930003347 taxol Natural products 0.000 claims 3
- 230000001028 anti-proliferant Effects 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- LAWDSOAXOCOSPV-UHFFFAOYSA-N 3-(3-methylbut-2-enoxy)-4-(3-phenylprop-2-enoyl)xanthen-9-one Chemical compound CC(C)=CCOC1=CC=C(C(C2=CC=CC=C2O2)=O)C2=C1C(=O)C=CC1=CC=CC=C1 LAWDSOAXOCOSPV-UHFFFAOYSA-N 0.000 claims 1
- CXKQXJPYPVCTRV-UHFFFAOYSA-N 3-(3-methylbut-2-enoxy)-4-[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]xanthen-9-one Chemical compound COC1=C(OC)C(OC)=CC(C=CC(=O)C=2C3=C(C(C4=CC=CC=C4O3)=O)C=CC=2OCC=C(C)C)=C1 CXKQXJPYPVCTRV-UHFFFAOYSA-N 0.000 claims 1
- OTASAGXWHKUTLE-UHFFFAOYSA-N 3-methyl-2-phenyl-7-prop-2-enoxy-8-[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=CC(=O)C=2C3=C(C(C(C)=C(O3)C=3C=CC=CC=3)=O)C=CC=2OCC=C)=C1 OTASAGXWHKUTLE-UHFFFAOYSA-N 0.000 claims 1
- KIIIYRWSJOBHOG-UHFFFAOYSA-N 3-methyl-2-phenyl-8-(3-phenylprop-2-enoyl)-7-prop-2-enoxychromen-4-one Chemical compound C=CCOC1=CC=C2C(=O)C(C)=C(C=3C=CC=CC=3)OC2=C1C(=O)C=CC1=CC=CC=C1 KIIIYRWSJOBHOG-UHFFFAOYSA-N 0.000 claims 1
- MMUQJIZCXBOAIX-UHFFFAOYSA-N 3-methyl-7-(2-methylprop-2-enoxy)-2-phenyl-8-(3-phenylprop-2-enoyl)chromen-4-one Chemical compound C=1C=CC=CC=1C=CC(=O)C=1C(OCC(=C)C)=CC=C(C(C=2C)=O)C=1OC=2C1=CC=CC=C1 MMUQJIZCXBOAIX-UHFFFAOYSA-N 0.000 claims 1
- QUSIGHVTYVQSIO-UHFFFAOYSA-N 3-methyl-7-(2-methylprop-2-enoxy)-2-phenyl-8-[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=CC(=O)C=2C3=C(C(C(C)=C(O3)C=3C=CC=CC=3)=O)C=CC=2OCC(C)=C)=C1 QUSIGHVTYVQSIO-UHFFFAOYSA-N 0.000 claims 1
- FSWITLPOTVKWFR-UHFFFAOYSA-N 3-methyl-7-(3-methylbut-2-enoxy)-2-phenyl-8-(3-phenylprop-2-enoyl)chromen-4-one Chemical compound C=1C=CC=CC=1C=CC(=O)C=1C(OCC=C(C)C)=CC=C(C(C=2C)=O)C=1OC=2C1=CC=CC=C1 FSWITLPOTVKWFR-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- AEQVLDDVEGAKDQ-UHFFFAOYSA-N 4-(3-phenylprop-2-enoyl)-3-prop-2-enoxyxanthen-9-one Chemical compound C=CCOC1=CC=C(C(C2=CC=CC=C2O2)=O)C2=C1C(=O)C=CC1=CC=CC=C1 AEQVLDDVEGAKDQ-UHFFFAOYSA-N 0.000 claims 1
- NVLXRSGZLQABNZ-UHFFFAOYSA-N 4-[3-(3-methoxyphenyl)prop-2-enoyl]-3-(3-methylbut-2-enoxy)xanthen-9-one Chemical compound COC1=CC=CC(C=CC(=O)C=2C3=C(C(C4=CC=CC=C4O3)=O)C=CC=2OCC=C(C)C)=C1 NVLXRSGZLQABNZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- RXOWRTAJIBYVII-UHFFFAOYSA-N 8-[3-(3-methoxyphenyl)prop-2-enoyl]-3-methyl-7-(2-methylprop-2-enoxy)-2-phenylchromen-4-one Chemical compound COC1=CC=CC(C=CC(=O)C=2C3=C(C(C(C)=C(O3)C=3C=CC=CC=3)=O)C=CC=2OCC(C)=C)=C1 RXOWRTAJIBYVII-UHFFFAOYSA-N 0.000 claims 1
- 210000004293 Mammary Glands, Human Anatomy 0.000 claims 1
- 206010058825 Menopausal disease Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 210000001672 Ovary Anatomy 0.000 claims 1
- 101700014436 RTN4 Proteins 0.000 claims 1
- 210000004291 Uterus Anatomy 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 125000005336 allyloxy group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000002648 combination therapy Methods 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 230000000069 prophylaxis Effects 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 0 CNC1=C(*)Oc2c(*=*)c(*)ccc2C1=O Chemical compound CNC1=C(*)Oc2c(*=*)c(*)ccc2C1=O 0.000 description 1
Claims (24)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9920910.8A GB9920910D0 (en) | 1999-09-03 | 1999-09-03 | Novel chalcones |
GB9920910.8 | 1999-09-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002108566A true RU2002108566A (en) | 2003-11-10 |
RU2252938C2 RU2252938C2 (en) | 2005-05-27 |
Family
ID=10860346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002108566/04A RU2252938C2 (en) | 1999-09-03 | 2000-08-28 | Chalcones and pharmaceutical compositions based on the same |
Country Status (21)
Country | Link |
---|---|
US (1) | US6620842B2 (en) |
EP (1) | EP1212315B1 (en) |
JP (1) | JP2003508527A (en) |
KR (1) | KR100819576B1 (en) |
CN (1) | CN1177843C (en) |
AT (1) | ATE235483T1 (en) |
AU (1) | AU776226B2 (en) |
CA (1) | CA2382130A1 (en) |
CZ (1) | CZ2002787A3 (en) |
DE (1) | DE60001851T2 (en) |
DK (1) | DK1212315T3 (en) |
ES (1) | ES2193106T3 (en) |
GB (1) | GB9920910D0 (en) |
HK (1) | HK1043999B (en) |
HU (1) | HUP0202579A3 (en) |
NO (1) | NO20021049L (en) |
PL (1) | PL353064A1 (en) |
PT (1) | PT1212315E (en) |
RU (1) | RU2252938C2 (en) |
SK (1) | SK3112002A3 (en) |
WO (1) | WO2001017988A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2482041C (en) | 2002-04-17 | 2012-06-05 | Cytokinetics, Inc. | 4-chromanone derivatives for treating cellular proliferative diseases and disorders |
US7638554B2 (en) * | 2002-04-18 | 2009-12-29 | Sri International | Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
US20030229136A1 (en) * | 2002-04-18 | 2003-12-11 | Nurulain Zaveri | Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
AU2003252025A1 (en) | 2002-07-17 | 2004-02-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US6864264B1 (en) | 2002-08-20 | 2005-03-08 | Gloria L. Anderson | 1-adamantyl chalcones for the treatment of proliferative disorders |
CN100336797C (en) * | 2005-08-19 | 2007-09-12 | 浙江大学 | Tetra substituted chalcone derivative and preparing method and use |
WO2013127361A1 (en) | 2012-03-01 | 2013-09-06 | The Hong Kong Polytechnic University | Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023341A (en) * | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
CA2084208A1 (en) * | 1990-05-17 | 1991-11-18 | Barry Markaverich | Growth inhibitors and methods of treating cancer and cell proliferative diseases |
IT1271301B (en) | 1994-12-20 | 1997-05-27 | Indena Spa | NATURAL AND SYNTHETIC CALCONES AND THEIR ESTERS WITH ANTI-PROLIFERATIVE ACTIVITY IN CANCER OF THE UTERUS, OVARIAN AND BREAST AND FORMULATIONS CONTAINING THEM |
US5525625A (en) | 1995-01-24 | 1996-06-11 | Warner-Lambert Company | 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
-
1999
- 1999-09-03 GB GBGB9920910.8A patent/GB9920910D0/en not_active Ceased
-
2000
- 2000-08-28 DE DE60001851T patent/DE60001851T2/en not_active Expired - Fee Related
- 2000-08-28 PL PL00353064A patent/PL353064A1/en not_active IP Right Cessation
- 2000-08-28 DK DK00964042T patent/DK1212315T3/en active
- 2000-08-28 CN CNB008123039A patent/CN1177843C/en not_active Expired - Fee Related
- 2000-08-28 ES ES00964042T patent/ES2193106T3/en not_active Expired - Lifetime
- 2000-08-28 EP EP00964042A patent/EP1212315B1/en not_active Expired - Lifetime
- 2000-08-28 WO PCT/EP2000/008366 patent/WO2001017988A1/en active IP Right Grant
- 2000-08-28 AT AT00964042T patent/ATE235483T1/en not_active IP Right Cessation
- 2000-08-28 RU RU2002108566/04A patent/RU2252938C2/en not_active IP Right Cessation
- 2000-08-28 JP JP2001522211A patent/JP2003508527A/en not_active Withdrawn
- 2000-08-28 CA CA002382130A patent/CA2382130A1/en not_active Abandoned
- 2000-08-28 SK SK311-2002A patent/SK3112002A3/en unknown
- 2000-08-28 AU AU75109/00A patent/AU776226B2/en not_active Ceased
- 2000-08-28 HU HU0202579A patent/HUP0202579A3/en unknown
- 2000-08-28 CZ CZ2002787A patent/CZ2002787A3/en unknown
- 2000-08-28 KR KR1020027002798A patent/KR100819576B1/en not_active IP Right Cessation
- 2000-08-28 PT PT00964042T patent/PT1212315E/en unknown
-
2002
- 2002-02-15 US US10/075,626 patent/US6620842B2/en not_active Expired - Fee Related
- 2002-03-01 NO NO20021049A patent/NO20021049L/en not_active Application Discontinuation
- 2002-08-01 HK HK02105661.5A patent/HK1043999B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002108565A (en) | New derivatives of flavones, xanthones and coumarins | |
KR930700490A (en) | Thiophene sulfonamide useful as carbonic anhydrase inhibitor | |
RU2002108567A (en) | Chalcon Coumarins | |
JP2003508524A5 (en) | ||
KR940014374A (en) | 6,7-modified paclitaxel | |
RU2483061C2 (en) | Tetrahydropyranochromen gamma-secretase inhibitors | |
KR910004580A (en) | New compounds | |
KR950002755A (en) | Inhibition of phosphatidylinositol 3-kinase by wortmannin and its analogs | |
AR046297A1 (en) | DPP INHIBITORS - IV METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE AGENTS | |
RU95113086A (en) | Derivatives of 5-membered heteroaryloxazolidinone as a mixture of isomers and separate isomers, their salts and s-oxides and pharmaceutical composition showing antibacterial activity based on thereof | |
RU97106776A (en) | NEW PROSTAGLANDINSINTAZY INHIBITORS | |
SE8501452D0 (en) | NEW 4-AROYLIMIDAZOL-2-ONER | |
EA200000731A1 (en) | ALPHA-AMINOAMID DERIVATIVES, USEFUL AS ANALGETIC AGENTS | |
RU2350609C2 (en) | Benzofuran and benzothiophen derivatives applied for hyperproliferative disease treatment | |
RU2002108566A (en) | New Chalcones | |
JP2005535731A5 (en) | ||
RU95114385A (en) | APPLICATION OF COMBINATION OF COMPOUNDS FOR THE INHIBITION OF OSTEOPOROSIS, PHARMACEUTICAL PREPARATION | |
JP2008545718A5 (en) | ||
JP2003508523A5 (en) | ||
AR030007A1 (en) | CYCLOHEXILO COMPOUND, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, DIAGNOSTIC AGENT, PHARMACEUTICAL COMPOSITION CONTAINING IT, PROCESS FOR PREPARATION, COMPOUNDS FOR ITS EXCLUSIVE USE IN THE PREPARATION OF SUCH CYCLODOOD METHODOIL COMPOUNDS, | |
KR930702288A (en) | Taizolidinedione Derivatives | |
DE69717044D1 (en) | Flavone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
FI911615A (en) | NYA 4-QUINOLYL-DIHYDROPYRIDINER, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL. | |
RU2220965C2 (en) | Sulfonamide-substituted compounds and pharmaceutical composition based on thereof | |
JP2003508527A5 (en) |